[Apropos of A. Lortholary's review: "Paraneoplastic syndromes (I)"]

Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV).

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg-1 per day starting dose of oral corticosteroids to treat bullous pemphigoid.

The British journal of dermatology·2021

Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study.

The British journal of dermatology·2021

Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

[Effects of phytoestrogens on prognosis and hormonal markers of breast cancer: A systematic review of randomized controlled trials].

Bulletin du cancer·2026

[Indications for chimerism analysis on sorted cell populations after allogeneic hematopoietic stem cell transplantation (SFGM-TC)].

Bulletin du cancer·2026

[Telemonitoring in Oncology: A French overview between 2022 and 2025].

Bulletin du cancer·2026

[Antibiotic use following pediatric hematopoietic stem cell transplantation (SFGM-TC)].

Bulletin du cancer·2026

[Facing a patient's wish to hasten death in palliative care: Professionals' experiences, practices, and interactional adjustments].

Bulletin du cancer·2026

[Evolving strategies for relapsed multiple myeloma: Toward personalized treatment in 2026].

Bulletin du cancer·2026

Integrated evaluation of umbilical cord mesenchymal stromal cell-derived extracellular vesicles across skin-related cellular and zebrafish models.

Frontiers in bioengineering and biotechnology·2026

Effect of BMI-stratified management based on the meridian-lymph axis theory on lower extremity lymphedema after gynecological cancer surgery: a randomized controlled trial.

Frontiers in oncology·2026

Toxicoproteomics of APAP-exposed HepG2 cells identifies candidate translational biomarkers of liver injury and recovery.

Frontiers in pharmacology·2026

[KMT2A-rearranged acute lymphoblastic leukemia with lineage switch following relapse: a case report and literature review].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

Notation System for Liver Transplant Recipients: Key Information in Transplant Procedure.

Journal of hepato-biliary-pancreatic sciences·2026

Confocal Ex Vivo Margin Assessment in Transoral Laser Cordectomy: A Pilot Diagnostic Accuracy Study.

The Laryngoscope·2026

Related Experiment Videos

[Apropos of A. Lortholary's review: "Paraneoplastic syndromes (I)"]

Related Concept Videos

Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV).

European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.

European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg-1 per day starting dose of oral corticosteroids to treat bullous pemphigoid.

Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study.

Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).

[Effects of phytoestrogens on prognosis and hormonal markers of breast cancer: A systematic review of randomized controlled trials].

[Indications for chimerism analysis on sorted cell populations after allogeneic hematopoietic stem cell transplantation (SFGM-TC)].

[Telemonitoring in Oncology: A French overview between 2022 and 2025].

[Antibiotic use following pediatric hematopoietic stem cell transplantation (SFGM-TC)].

[Facing a patient's wish to hasten death in palliative care: Professionals' experiences, practices, and interactional adjustments].

[Evolving strategies for relapsed multiple myeloma: Toward personalized treatment in 2026].

Integrated evaluation of umbilical cord mesenchymal stromal cell-derived extracellular vesicles across skin-related cellular and zebrafish models.

Effect of BMI-stratified management based on the meridian-lymph axis theory on lower extremity lymphedema after gynecological cancer surgery: a randomized controlled trial.

Toxicoproteomics of APAP-exposed HepG2 cells identifies candidate translational biomarkers of liver injury and recovery.

[KMT2A-rearranged acute lymphoblastic leukemia with lineage switch following relapse: a case report and literature review].

Notation System for Liver Transplant Recipients: Key Information in Transplant Procedure.

Confocal Ex Vivo Margin Assessment in Transoral Laser Cordectomy: A Pilot Diagnostic Accuracy Study.

Related Experiment Videos

[Apropos of A. Lortholary's review: "Paraneoplastic syndromes (I)"]

Related Concept Videos

Related Articles